MILLENNIUM MANAGEMENT LLC

Position in TCRX — TScan Therapeutics, Inc.

CIK 1273087 NEW YORK, NY

Position in TCRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,474,887

+$1,071,269 QoQ

Shares Held

1,460,285

+261.8% QoQ

Ownership

2.23%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $4,468,729,571 across 342 Biotechnology names. TCRX ranks #256 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	1,262,511	$238,677,704
2	INSM	INSMED Inc	1,157,786	$189,321,166
3	BMRN	Biomarin Pharmaceutical Inc	3,010,308	$170,052,298
4	TERN	Terns Pharmaceuticals, Inc.	3,011,558	$158,769,337
5	ALNY	Alnylam Pharmaceuticals, Inc.	447,887	$148,192,371
6	FOLD	AMICUS THERAPEUTICS, INC.	7,908,459	$114,356,317
7	ARDX	Ardelyx, Inc.	17,842,370	$106,875,796
8	BLTE	Belite Bio, Inc	570,088	$90,894,830

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,474,887	1,460,285	+261.8%	Shares	Sole	2026-05-15
2025-12-31	$403,618	403,618	-13.4%	Shares	Sole	2026-02-17
2025-09-30	$848,276	466,086	-26.0%	Shares	Sole	2025-11-14
2025-06-30	$913,700	630,138	+172.6%	Shares	Sole	2025-08-14
2025-03-31	$319,021	231,175	+375.0%	Shares	Sole	2025-05-15
2024-09-30	$242,386	48,672	+74.5%	Shares	Sole	2024-11-14
2024-06-30	$163,150	27,889	-92.9%	Shares	Sole	2024-08-14
2024-03-31	$3,113,393	392,115	+295.7%	Shares	Sole	2024-05-15
2023-12-31	$577,648	99,082	+414.9%	Shares	Sole	2024-02-14
2022-12-31	$29,828	19,244	+56.8%	Shares	Sole	2023-02-14
2021-12-31	$55,242	12,276	-59.4%	Shares	Sole	2022-02-14
2021-09-30	$252,201	30,240	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.